成(cheng)(cheng)(cheng)(cheng)都(dou)華(hua)(hua)(hua)(hua)神(shen)(shen)科(ke)技(ji)(ji)集團股(gu)份有限(xian)(xian)公(gong)司[深(shen)圳證(zheng)券交(jiao)易所股(gu)票代(dai)碼:000790,簡(jian)稱:華(hua)(hua)(hua)(hua)神(shen)(shen)科(ke)技(ji)(ji)],始創于(yu)1988年,華(hua)(hua)(hua)(hua)神(shen)(shen)科(ke)技(ji)(ji)起源于(yu)成(cheng)(cheng)(cheng)(cheng)都(dou)中醫(yi)(yi)藥(yao)大學(xue)附屬制藥(yao)廠,是以現代(dai)中藥(yao)、生(sheng)(sheng)物制藥(yao)、中醫(yi)(yi)連鎖、醫(yi)(yi)美、全(quan)周(zhou)期生(sheng)(sheng)命(ming)養護為(wei)主營業務的大健康全(quan)產業鏈(lian)國家重點高新技(ji)(ji)術企業。華(hua)(hua)(hua)(hua)神(shen)(shen)科(ke)技(ji)(ji)由華(hua)(hua)(hua)(hua)神(shen)(shen)科(ke)技(ji)(ji)集團制藥(yao)廠、成(cheng)(cheng)(cheng)(cheng)都(dou)華(hua)(hua)(hua)(hua)神(shen)(shen)艾草科(ke)技(ji)(ji)有限(xian)(xian)公(gong)司、成(cheng)(cheng)(cheng)(cheng)都(dou)中醫(yi)(yi)藥(yao)大學(xue)華(hua)(hua)(hua)(hua)神(shen)(shen)藥(yao)業有限(xian)(xian)責任(ren)公(gong)司、成(cheng)(cheng)(cheng)(cheng)都(dou)華(hua)(hua)(hua)(hua)神(shen)(shen)生(sheng)(sheng)物技(ji)(ji)術有限(xian)(xian)責任(ren)公(gong)司以及四川華(hua)(hua)(hua)(hua)神(shen)(shen)鋼構有限(xian)(xian)責任(ren)公(gong)司等全(quan)資(zi)或控股(gu)子公(gong)司組成(cheng)(cheng)(cheng)(cheng),員工近1200人(ren)。
華神(shen)科(ke)技(ji)依托(tuo)“國(guo)家(jia)級企業技(ji)術中心”和“博士后(hou)科(ke)研(yan)(yan)工(gong)作(zuo)(zuo)站”等重(zhong)點資源及融合平臺(tai),與包括(kuo)四川(chuan)大(da)學、成都中醫藥大(da)學在內(nei)(nei)的國(guo)內(nei)(nei)外數十所高等院(yuan)校(xiao)、科(ke)研(yan)(yan)院(yuan)所及知名醫院(yuan)建立了開放式的、互利(li)共(gong)贏的“產、學、研(yan)(yan)”一體化(hua)合作(zuo)(zuo)平臺(tai)。華神(shen)科(ke)技(ji)先后(hou)承擔了國(guo)家(jia)、省、市重(zhong)大(da)科(ke)研(yan)(yan)項(xiang)(xiang)目50余項(xiang)(xiang),共(gong)獲得國(guo)際、國(guo)內(nei)(nei)發(fa)明專利(li)100余項(xiang)(xiang),共(gong)獲得省部級以上(shang)科(ke)技(ji)進步獎10項(xiang)(xiang)。其中包括(kuo)授(shou)權國(guo)際專利(li)3項(xiang)(xiang),分別含德國(guo)、法(fa)國(guo)、意大(da)利(li)、荷蘭、英國(guo)5個國(guo)家(jia)專利(li),為集團的發(fa)展提供(gong)了強(qiang)大(da)的技(ji)術、項(xiang)(xiang)目支撐與創新賦能。